Akari Therapeutics Plc Adr (AKTX)

Jul 25, 2026

Akari Therapeutics Plc Sponsored ADR Revenue Breakdown – LS:A4270Y - TradingView

Jul 25, 2026

Jul 22, 2026

Stock Ratings | Morgan Stanley raised its target price for Intel (INTC) to $75; Maxim Group initiated coverage on Rein Therapeutics (RNTX) with a target price of $4, representing a potential gain of 373.93%. - Sahm

Jul 22, 2026

Jul 22, 2026

Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity - Sahm

Jul 22, 2026

Jul 21, 2026

Akari Therapeutics partners with Whitehawk on dual payload study By Investing.com - Investing.com South Africa

Jul 21, 2026

Jul 21, 2026

Akari Therapeutics partners with Whitehawk on dual payload study - Investing.com

Jul 21, 2026

Jul 21, 2026

Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics - Sahm

Jul 21, 2026

Jul 20, 2026

Price to earnings forward of Akari Therapeutics Plc Sponsored ADR – TRADEGATE:CLA1 - TradingView

Jul 20, 2026

Jul 10, 2026

Form S-3/A Akari Therapeutics PLC For: 10 July By Investing.com - Investing.com South Africa

Jul 10, 2026

Jul 10, 2026

Akari Therapeutics (NASDAQ: AKTX) files to register 5.99M ADSs from May 2026 private placement - Stock Titan

Jul 10, 2026

Jul 08, 2026

Akari Therapeutics (NASDAQ: AKTX) adds private‑placement warrants and purchase agreement exhibits - Stock Titan

Jul 08, 2026

Jul 07, 2026

Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific Advisory Board - Finviz

Jul 07, 2026

Jul 07, 2026

Akari Therapeutics appoints Patricia LoRusso to advisory board - Investing.com

Jul 07, 2026

Jul 07, 2026

Akari Therapeutics appoints Patricia LoRusso to advisory board By Investing.com - Investing.com India

Jul 07, 2026

Jul 02, 2026

Akari Therapeutics (NASDAQ: AKTX) registers 5,999,999 ADSs, 80,000-shares each - Stock Titan

Jul 02, 2026

Jun 29, 2026

Akari Therapeutics completes $8.3m capital raise in Q2 - Investing.com

Jun 29, 2026

Jun 29, 2026

Akari Therapeutics completes $8.3m capital raise in Q2 By Investing.com - Investing.com India

Jun 29, 2026

Jun 29, 2026

AKTXAkari Therapeutics Plc ADR Options - Finviz

Jun 29, 2026

Jun 27, 2026

Form S-1/A Akari Therapeutics PLC For: 26 June By Investing.com - Investing.com South Africa

Jun 27, 2026

Jun 26, 2026

White Lion resale of 2.5M Akari (NASDAQ: AKTX) ADSs under $25M equity deal - Stock Titan

Jun 26, 2026

Jun 26, 2026

AKTX Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 26, 2026

Akari Therapeutics Plc Sponsored ADR Actuals & Estimates (NASDAQ:AKTX) - TradingView

Jun 26, 2026

Jun 26, 2026

CLA1 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Jun 25, 2026

Form 4 Akari Therapeutics PLC For: 25 June By Investing.com - Investing.com India

Jun 25, 2026

Jun 25, 2026

Akari Therapeutics (AKTX) CEO granted stock options tied to ADS and financings - Stock Titan

Jun 25, 2026

Jun 25, 2026

Akari Therapeutics (AKTX) interim CFO granted new ADS awards - Stock Titan

Jun 25, 2026

Jun 25, 2026

A4270Y Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 13, 2026

AKTX Options Chain — NASDAQ:AKTX - TradingView

Jun 13, 2026

Jun 12, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jun 12, 2026

Jun 08, 2026

Akari Therapeutics PLC (FRA:CLA1) Valuation - GuruFocus

Jun 08, 2026

Jun 07, 2026

VNET Group, Akari Therapeutics and other big stocks moving lower in Tuesday's pre-market session - MSN

Jun 07, 2026

Jun 05, 2026

Akari Therapeutics Q1 2026 Earnings: EPS Misses Estimates but Stock Rises 5.7% on Pipeline HopeSurprise Factor Analysis - dars.gov.et

Jun 05, 2026

Jun 04, 2026

Large share issuance and governance votes ahead at Akari (NASDAQ: AKTX) 2026 AGM - Stock Titan

Jun 04, 2026

Jun 04, 2026

Akari Therapeutics partners with WuXi XDC on ADC development - Investing.com

Jun 04, 2026

May 30, 2026

Diluted earnings per share (diluted EPS) of Akari Therapeutics Plc Sponsored ADR – TRADEGATE:CLA1 - TradingView

May 30, 2026

May 29, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Sahm

May 29, 2026

May 28, 2026

Which stocks have an unusual volume on Thursday? - ChartMill

May 28, 2026

May 26, 2026

VNET Group, Akari Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

May 26, 2026

May 23, 2026

Akari Therapeutics Soars as KRAS ADC Data Triggers Rerating - timothysykes.com

May 23, 2026

May 22, 2026

Akari Therapeutics (AKTX) AGM June 30, 2026 — equity authorizations, warrants/ADSs - Stock Titan

May 22, 2026

May 22, 2026

Akari Therapeutics (NASDAQ: AKTX) sets $5.5M ADS and warrant private placement - Stock Titan

May 22, 2026

May 22, 2026

Keep an eye on the top gainers and losers in Friday's session. - ChartMill

May 22, 2026

May 22, 2026

Friday's session: gap up and gap down stocks - ChartMill

May 22, 2026

May 22, 2026

Discover the top movers in Friday's pre-market session. - ChartMill

May 22, 2026

May 22, 2026

Akari Therapeutics Announces $5.5 Million Private Placement Offering - Sahm

May 22, 2026

May 21, 2026

Akari Therapeutics stock rockets 50% higher on KRAS combination data - Investing.com

May 21, 2026

May 21, 2026

Akari Therapeutics prices $5.5 million private placement By Investing.com - Investing.com South Africa

May 21, 2026

May 21, 2026

Akari Therapeutics prices $5.5 million private placement - Investing.com

May 21, 2026

May 15, 2026

Why Akari Therapeutics Stock Is Surging On Thursday? - Sahm

May 15, 2026

May 13, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm

May 13, 2026

May 12, 2026

Akari Therapeutics secures European patent for ADC payload - Investing.com

May 12, 2026